News

Newsletter

12 de June de 2019

Brazilian regulatory agency (ANVISA) inaugurates discussion on cannabis for medicinal and scientific purposes

ANVISA’s Board of Directors approved the proposal to open two Public Consultations to regulate:
(i) the cultivation of the cannabis spp. for medical and scientific purposes; and
(ii) a specific procedure for registration and monitoring of medicines based on Cannabis spp., its derivatives, and synthetic analogs.
 
For further information, click below to access our full newsletter.
Back

Last related news

19 de September de 2025

Transition to Regulatory Agency and New Responsibilities under the Digital Child and Adolescent Statute

The past few days have brought significant developments for the National Data Protection Agency (“ANPD”). Firstly, Provisional Measure No. 1,317/2025 was published Transition to Regulatory Agency and New Responsibilities under the Digital Child and Adolescent Statute

Ler notícia

27 de August de 2025

Temporary Use of Unlicensed Software: Legal Liability Regardless of Duration

Companies often argue, during audits, that the use of unlicensed software occurred only briefly—over a few days or weeks—as a way to Temporary Use of Unlicensed Software: Legal Liability Regardless of Duration

  • Kasznar Leonardos
  • Ler notícia

    22 de August de 2025

    Update from Brazil: The Debate on Platform Monetization and Accountability

    A significant debate has recently emerged in Brazil following an episode involving the creator Felca. The controversy centered on the adultization of Update from Brazil: The Debate on Platform Monetization and Accountability

    Ler notícia